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Local CTLA41g gene transfer directly to the graft may have the potential to avoid the opportunistic infections 
and malignancies by systemic immunosuppression. 1n our previous studies using Bio-Breeding (BB) rats, local 
Adenovirus-mediated (Ad.) CTLA41g gene transfer could prevent the pancreas from autoimmune and 
alloimmune responses. This study investigated the potency of CD28/B7 costimulatory blockade by local Ad. 
CTLA41g gene transfer for induction of donor-specific tolerance and further examined the underlying 
mechanisms. 
〔方法〕
Brown Norway (BN ; RT1 n)-pancreaticoduodenal grafts transfected with Ad. CTLA41g via intraarterial ex vivo 
perfusion were transplanted into streptozotocin-induced diabetic Lewis (LEW ; RTP) rats. FK506 was used as 
an immunosuppressive agent for 3 days at a dose of 1 mg/kg on the day before, the day of, and the day after 
pancreas transplantation (PTx). Expression of CTLA41g in the graft was detected by immunohistochemical 
staining. T lymphocytes were harvested and separated from spleen for mixed lymphocyte reaction (MLR) and 
cell-mediated lymphocytotoxicity (CML) assays. Flow cytometry was used for the analysis of splenic T-cell 
subpopulations from the tolerant recipients. 
[結果〕
Local Ad. CTLA41g gene transfer significantly prolonged graft survivals (>59.3 days). Further, the gene 
transfer indefinitely prolonged graft survivals (> 156 days) when combined with a short course of FK506. 
CTLA41g was predominantly expressed in the grafts on day 4 posttransplantation. The expression was 
gradually diminished and was only slightly detectable at day > 100. 1n the tolerant rats, proliferative 
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responses against BN antigens were inhibited up to the similar level which was comparable to those of naive rats. 
The T cells from tolerant recipients (> 100 days) also showed poor cytotoxic responses. In the adoptive transfer 
experiment, the splenic T cells of tolerant recipients were able to suppress the rejection of BN, but not 
third -party Wistar Furth (WF ;問、1u) , cardiac grafts in irradiated (480 cGy) LEW recipients. The percentage of 
CD4十 CD25+ splenic T-cells was significantly increased in tolerant recipients (13.53:t4.06% vs. 6.06:t0.56% in 
naive rats). 
〔総括〕
1. CTLA4Ig gene tranfer to the pancreaticoduodenal allograft combined with a short course of FK506 induced 
an indefinite graft survival. 
2 . InMLR, proliferative responses of tolerant splenic T cells against BN antigen were inhibited up to the similar 
level which was comparable to those of naive rats ; In CML, splenic T cells from the tolerant recipients 
showed poor cytotoxic responses compared with those from naive or rejected recipients. 
3. In the second cardiac graft challenge, a donor-specific tolerance was obtained. 
4. Adoptive transfer experiments indicated the presence of immunoregulatory cells, CD4 十CD25+ T cells, in the 
maintenance phase of tolerance. 
We concluded that development of donor-specific immunoregulatory T cells might be responsible for the 




抑制療法を行い、 ドナー抗原特異的な免疫寛容の誘導を可能にした。免疫抑制の方法は T 細胞の活性化に不可欠な
B7-CD28 分子間相互作用による共刺激(二次、ングナル)を抑制する CTLA4Ig を移植梓へ直接遺伝子導入し、さらに
術前後の 3 日間 FK506 を併用した。
寛容が成立したレシピエント牌 T 細胞を用いた MLR での増殖応答、ならびに CML での細胞傷害性は抗原特異的
に抑制されており、さらに、同細胞の養子移入実験により、 ドナー心の生着を認めた。この免疫寛容の機序は免疫制
御 T 細胞の誘導によるものであると考えられた。
以上より、本研究は臓器移植における、より理想的な免疫抑制療法として意義深く、学位に値するものと考える。
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